These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32349553)

  • 21. GI infections are associated with an increased risk of Parkinson's disease.
    Nerius M; Doblhammer G; Tamgüney G
    Gut; 2020 Jun; 69(6):1154-1156. PubMed ID: 31201287
    [No Abstract]   [Full Text] [Related]  

  • 22. A punch in the gut - Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease.
    Becker A; Faßbender K; Oertel WH; Unger MM
    Parkinsonism Relat Disord; 2019 Mar; 60():43-45. PubMed ID: 30292735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The microbiota-gut-brain axis and circadian rhythms in Parkinson's disease - Correspondence.
    Zandi M; Hashemnia SMR; Shafaati M
    Int J Surg; 2022 Dec; 108():106978. PubMed ID: 36347440
    [No Abstract]   [Full Text] [Related]  

  • 24. Gut microbiota: Implications in Parkinson's disease.
    Parashar A; Udayabanu M
    Parkinsonism Relat Disord; 2017 May; 38():1-7. PubMed ID: 28202372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Exploration of
    Ni GX; Song YY
    Zhongguo Zhen Jiu; 2020 Mar; 40(3):315-7. PubMed ID: 32270648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?
    Scheperjans F; Pekkonen E; Kaakkola S; Auvinen P
    J Parkinsons Dis; 2015; 5(2):255-62. PubMed ID: 25882059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2021 Workshop: Neurodegenerative Diseases in the Gut-Brain Axis-Parkinson's Disease.
    Mawe GM; Browning KN; Manfredsson FP; Camilleri M; Hamilton FA; Hollander JA; Sieber BA; Greenwel P; Shea-Donohue T; Wiley JW
    Gastroenterology; 2022 May; 162(6):1574-1582. PubMed ID: 35149029
    [No Abstract]   [Full Text] [Related]  

  • 28. Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model.
    Lee JY; Tuazon JP; Ehrhart J; Sanberg PR; Borlongan CV
    J Cell Mol Med; 2019 Aug; 23(8):5466-5474. PubMed ID: 31148353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The gut in Parkinson's disease: Bottom-up, top-down, or neither?
    Leclair-Visonneau L; Neunlist M; Derkinderen P; Lebouvier T
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13777. PubMed ID: 31854093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models.
    Pellegrini C; Colucci R; Antonioli L; Barocelli E; Ballabeni V; Bernardini N; Blandizzi C; de Jonge WJ; Fornai M
    Neurogastroenterol Motil; 2016 Dec; 28(12):1781-1791. PubMed ID: 27611012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gut microbiome and psyche: paradigm shift in the concept of brain-gut axis].
    Konturek PC; Zopf Y
    MMW Fortschr Med; 2016 May; 158 Suppl 4():12-6. PubMed ID: 27221556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
    Fang X
    Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction: The Gut-Brain Axis in Parkinson's Disease.
    van Laar T
    J Parkinsons Dis; 2019; 9(s2):S279. PubMed ID: 31683490
    [No Abstract]   [Full Text] [Related]  

  • 34. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
    Sharma S; Awasthi A; Singh S
    Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota in patients with Parkinson's disease in southern China.
    Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
    Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.
    Ghaisas S; Maher J; Kanthasamy A
    Pharmacol Ther; 2016 Feb; 158():52-62. PubMed ID: 26627987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson's disease.
    Mulak A
    Mov Disord; 2018 Mar; 33(3):398-401. PubMed ID: 29436731
    [No Abstract]   [Full Text] [Related]  

  • 39. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease.
    Qian Y; Yang X; Xu S; Huang P; Li B; Du J; He Y; Su B; Xu LM; Wang L; Huang R; Chen S; Xiao Q
    Brain; 2020 Aug; 143(8):2474-2489. PubMed ID: 32844199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.